Remove 2025 Remove Drugs Remove FDA Approval
article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Drugs.com

WEDNESDAY, June 11, 2025 -- The U.S. Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults.The combination pill is the first and only FDA-approved triple combination.

article thumbnail

FDA Approves First Twice-a-Year HIV Prevention Shot, Yeztugo

Drugs.com

FRIDAY, June 20, 2025 — A new shot to prevent HIV infection has just been approved — and it only needs to be taken twice a year. Food and Drug Administration (FDA) approved lenacapavir, a long-acting injection. On Wednesday, the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves First Twice-a-Year HIV Prevention Shot

Drugs.com

FRIDAY, June 20, 2025 — A new shot to prevent HIV infection has just been approved — and it only needs to be taken twice a year.On Food and Drug Administration (FDA) approved lenacapavir, a long-acting injection that was shown to. Wednesday, the U.S.

article thumbnail

FDA Approves Once-Monthly Andembry for Hereditary Angioedema

Drugs.com

FRIDAY, June 20, 2025 -- The U.S. Food and Drug Administration has approved Andembry (garadacimab-gxii) as the only treatment targeting factor XIIa for prophylactic use to prevent attacks of hereditary angioedema (HAE). According to the Mayo.

article thumbnail

FDA Approves Susvimo for Diabetic Macular Edema

Drugs.com

5, 2025 -- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic. WEDNESDAY, Feb.

article thumbnail

FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis

Drugs.com

MONDAY, June 30, 2025 -- The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active lupus nephritis who are receiving standard therapy. Benlysta.

article thumbnail

Novavax COVID Vaccine Moves Closer to Full FDA Approval

Drugs.com

FRIDAY, April 25, 2025 Novavaxs COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday.The update sent Novavaxs stock up more than 21% in early trading. It also helped ease.